A paradigm shift in the prevention and diagnosis of oral squamous cell carcinoma

Abstract

AbstractBackgroundOral squamous cell carcinoma (OSCC) is a widespread disease with only 50%–60% 5‐year survival. Individuals with potentially malignant precursor lesions are at high risk.MethodsSurvival could be increased by effective, affordable, and simple screening methods, along with a shift from incisional tissue biopsies to non‐invasive brush biopsies for cytology diagnosis, which are easy to perform in primary care. Along with the explainable, fast, and objective artificial intelligence characterisation of cells through deep learning, an easy‐to‐use, rapid, and cost‐effective methodology for finding high‐risk lesions is achievable. The collection of cytology samples offers the further opportunity of explorative genomic analysis.ResultsOur prospective multicentre study of patients with leukoplakia yields a vast number of oral keratinocytes. In addition to cytopathological analysis, whole‐slide imaging and the training of deep neural networks, samples are analysed according to a single‐cell RNA sequencing protocol, enabling mapping of the entire keratinocyte transcriptome. Mapping the changes in the genetic profile, based on mRNA expression, facilitates the identification of biomarkers that predict cancer transformation.ConclusionThis position paper highlights non‐invasive methods for identifying patients with oral mucosal lesions at risk of malignant transformation. Reliable non‐invasive methods for screening at‐risk individuals bring the early diagnosis of OSCC within reach. The use of biomarkers to decide on a targeted therapy is most likely to improve the outcome. With the large‐scale collection of samples following patients over time, combined with genomic analysis and modern machine‐learning‐based approaches for finding patterns in data, this path holds great promise.